Stocks and Investing Stocks and Investing
Mon, October 21, 2019
Fri, October 18, 2019
Thu, October 17, 2019
Wed, October 16, 2019
Tue, October 15, 2019
Mon, October 14, 2019
Fri, October 11, 2019

Matthew Harrison Maintained (BIIB) at Sell with Increased Target to $212 on, Oct 11th, 2019


Published on 2024-10-26 16:50:36 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Sell with Increased Target from $211 to $212 on, Oct 11th, 2019.

Matthew has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, all agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Hold with Increased Target to $285 on, Wednesday, July 24th, 2019
  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $250 on, Friday, June 28th, 2019